← Open Payments lookup

MELISSA STIPP: Open Payments

NPI 1922676204 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$572 in 37 payments from 13 companies in 2025. Trend: 2023 $107 · 2024 $378 · 2025 $572

Food & beverage: $572
CompanyPaymentsAmount
ABBVIE INC.16$172
Axsome Therapeutics, Inc.6$110
Vanda Pharmaceuticals Inc.3$66
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$53
GENZYME CORPORATION1$29
Corcept Therapeutics1$24
Indivior Inc.1$21
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$18
Phathom Pharmaceuticals, Inc.1$17
Madrigal Pharmaceuticals1$16

Products named: Auvelity, VRAYLAR, FANAPT, CAPLYTA, RINVOQ, DUPIXENT, QULIPTA, Korlym.

Industry payments across KY — which companies pay providers there.